Physician profile
Joel Phillips
NPI 1598267585
$1,122.94
in general payments reported to CMS, 2019-2025
11 companies · $273 in 2025
The $273 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $53.93 · 2021: $64.89 · 2022: $17.43 · 2023: $689 · 2024: $24.58 · 2025: $273.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $987.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $986.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cerapedics INC. | $329.58 | 2023 | I-Factor Peptide Enhanced Bone Graft |
| Boston Scientific Corporation | $205.43 | 2025 | Accolade Sr, Wavewriter Alpha Prime 16 |
| Wenzel Spine, INC. | $198.44 | 2023 | Varilift |
| Nevro Corp. | $146.46 | 2023 | Senza |
| Globus Medical, INC. | $68.02 | 2025 | Senza |
| Medtronic USA, INC. | $53.93 | 2020 | |
| Medtronic, INC. | $50.94 | 2021 | |
| Abbott Laboratories | $24.58 | 2024 | Eterna |
| Depuy Synthes Sales INC. | $17.43 | 2022 | |
| Abbvie INC. | $14.18 | 2023 | |
| Horizon Therapeutics Plc | $13.95 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joel Phillips listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.